Participate In Research

Leukemia4 Results found

Studies recruiting participants:

Treatment-free Remission Accomplished With Dasatinib in Patients With CML (TRAD)

The purpose of this study is to find out how to increase the potential for achieving an "operational cure" from chronic myeloid leukemia. An "operational cure" is a state in which a person does not require further treatment, although there may be some remaining cancer cells.

Recruiting

Principal Investigator

Donna Forrest

Body Locations and Systems

Leukemia

Area

Vancouver

Age

18 and above

Ibrutinib in Combination With Corticosteroids Versus Placebo in Combination With Corticosteroids in Subjects With New Onset Chronic Graft Versus Host…

To evaluate the safety and efficacy of ibrutinib in combination with prednisone in subjects with newly diagnosed moderate to severe cGVHD.

Recruiting

Principal Investigator

Raewyn Broady

Body Locations and Systems

Leukemia, Blood

Area

Vancouver

Age

12 and above

Closed for recruitment:

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)…

This study will compare the overall survival (OS) between treatment groups of patients treated with vosaroxin and cytarabine versus patients treated with placebo and cytarabine.

Closed for Recruitment

Principal Investigator

Donna E. Hogge

Body Locations and Systems

Leukemia

Area

Vancouver

Age

18 and above

A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT) (HELIOS)

The purpose of the study is to determine if overall mortality is affected one year after a hematopoietic stem cell transplant (HCT) in patients given a vaccine to prevent cytomegalovirus (CMV). Safety of ASP0113 in subjects undergoing allogeneic HCT will also be evaluated.

Closed for Recruitment

Principal Investigator

Raewyn Broady

Body Locations and Systems

Leukemia

Area

Vancouver

Age

18 and above

VCH Research Institute

Body Systems

Arteries (12)

Blood (32)

Heart (51)

Bones (7)

Hip, Leg and Foot (8)

Joints (11)

Shoulder, Arm and Hand (1)

Spine (4)

Brain (97)

Spinal Cord (6)

Large Intestine (13)

Liver (22)

Small Intestine (12)

Ear (1)

Nose (3)

Throat (1)

Pancreas (14)

Thyroid (1)

Eye Disorders (15)

HIV (1)

Immune System and Disorders (6)

Bladder (3)

Kidney (23)

Lungs (29)

Men's Health (30)

Women's Health (22)

Mouth (1)

Skin Conditions (17)

Disorders and Conditions

Diagnosis and Therapy

Leukemia4 Results found

Studies recruiting participants:

Treatment-free Remission Accomplished With Dasatinib in Patients With CML (TRAD)

Ibrutinib in Combination With Corticosteroids Versus Placebo in Combination With Corticosteroids in Subjects With New Onset Chronic Graft Versus Host…

Closed for recruitment:

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)…

A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT) (HELIOS)

Body Systems

Arteries (12)

Blood (32)

Heart (51)

Bones (7)

Hip, Leg and Foot (8)

Joints (11)

Shoulder, Arm and Hand (1)

Spine (4)

Brain (97)

Spinal Cord (6)

Large Intestine (13)

Liver (22)

Small Intestine (12)

Ear (1)

Nose (3)

Throat (1)

Pancreas (14)

Thyroid (1)

Eye Disorders (15)

HIV (1)

Immune System and Disorders (6)

Bladder (3)

Kidney (23)

Lungs (29)

Men's Health (30)

Women's Health (22)

Mouth (1)

Skin Conditions (17)

Disorders and Conditions

Diagnosis and Therapy

Leukemia4 Results found

Studies recruiting participants:

Treatment-free Remission Accomplished With Dasatinib in Patients With CML (TRAD)

Ibrutinib in Combination With Corticosteroids Versus Placebo in Combination With Corticosteroids in Subjects With New Onset Chronic Graft Versus Host…

Closed for recruitment:

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)…

A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT) (HELIOS)

Subscribe to our mailing list